New products

Medtronic launches remote glucose monitor for diabetics

Medtronic, Inc. has announced FDA approval of the first-of-its-kind mySentry Remote Glucose Monitor, which allows a parent or caregiver to monitor from another room a patient’s MiniMed Paradigm REAL-Time Revel System. The remote glucose monitor also marks the launch of a new category of Connected Care solutions that will provide people with diabetes and their caregivers convenient options to access their diabetes management information.

mySentry allows caregivers to see real-time insulin pump status and glucose trends, as well as hear alerts and alarms, at their bedside while an adult or child with diabetes sleeps in his or her own room. This could be especially useful for parents, who could be alerted through a predictive alarm in the middle of the night if their child’s glucose levels are falling, allowing them to take action to prevent an episode of low blood sugar (hypoglycemia). For a caregiver of someone with type 1 diabetes, nighttime hypoglycemia represents one of their greatest concerns.

An estimated 75 percent of all episodes of severe hypoglycemia in children occur at night. By alerting a parent or caregiver to an alarm, mySentry may provide added nighttime protection.

mySentry is used in conjunction with the MiniMed Paradigm REAL-Time Revel System, an insulin pump with built-in continuous glucose monitoring. mySentry can be placed in the bedroom or in any room throughout the house so all important information is just a glance away. mySentry provides flexibility and a wide range of uses including displaying all of the alerts and alarms available on the Paradigm Revel insulin pump: predictive alerts, continuous glucose monitoring (CGM) graph, insulin pump battery life, amount of insulin remaining, and time until the next glucose sensor calibration.

For more information, visit http://www.medtronicdiabetes.com/mysentry.

Posted January 19, 2012